Call for new drug discovery pilot projects at SciLifeLab DDD with special emphasis on new modalities and antibiotics
January 11, 2023 @ 11:00 – 11:45 CET
- Information of new DDD call in Anubis – Per Arvidsson
- ”Antibiotic research through DDD and Enable2” – Anders Karlén
- ”New modalities as therapies of the future” – Per Arvidsson
In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new pilot project proposals for drug discovery. All therapeutic modalities are of interest. Of special interest are new project ideas for new modalities including therapeutic oligonucleotides, and in collaboration with ENABLE2 https://www.ilk.uu.se/enable2/, projects for discovery of new antibiotics.
Note that shorter projects for selections in phage display libraries for antibodies and in DNA encoded chemical libraries for small molecules can be considered.
A description of new modalities in drug discovery research can be found here: https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00582
11.00 Introduction to Anubis call for DDD pilot-projects, Kristian Sandberg
11.05 Antibiotic drug discovery through ENABLE2 and DDD, Anders Karlén
11.15 Oligonucleotide therapeutics through OligoNova HUB at DDD, Pär Matsson
11.25 New therapeutic modalities and selection in enormous antibody and small molecule libraries, Per Arvidsson
11.40 Questions & Answers, Moderated by Kristian Sandberg
If you have questions about the call please contact DDD by email (email@example.com). This call is open for scientists with a doctoral degree at a Swedish university or higher institution. English should be used when filling out this application. You are responsible for ensuring that the application is complete. Incomplete applications will not be processed.